Background: There is increasing awareness that the goal of treatment in generalized anxiety disorder (GAD) should not simply be a response, but restoration of normal function. The aim of this study was to apply a novel psychotherapeutic approach for increasing the level of remission in GAD. Methods: Twenty patients with DSM-IV GAD devoid of comorbid conditions were randomly assigned to 8 sessions of cognitive behavioral therapy (CBT) or the sequential administration of 4 sessions of CBT followed by other 4 sessions of well-being therapy (WBT). Assessment methods included the Anxiety and Depression Scales of Paykel’s Clinical Interview for Depression, Ryff’s Psychological Well-being Scales and Kellner’s Symptom Questionnaire. A one-year follow-up was undertaken. Results: Significant advantages of the CBT-WBT sequential combination over CBT only were observed with both observer and self-rated methods after treatment. Such gains were maintained at follow-up. Conclusions: These preliminary results suggest the feasibility and clinical advantages of adding WBT to the treatment of GAD. They lend support to a sequential use of treatment components for achieving a more sustained recovery.

Keller MB: The long-term clinical course of generalized anxiety disorder. J Clin Psychiatry 2002;63(suppl 8):11–16.
Gorman JM: Treatment of generalized anxiety disorder. J Clin Psychiatry 2002;63(suppl 8):17–23.
Borkovec TD, Ruscio AM: Psychotherapy of generalized anxiety disorder. J Clin Psychiatry 2001;62(suppl 11):37–42.
Ryff CD, Singer B: Psychological well-being: Meaning, measurement and implication for psychotherapy research. Psychother Psychosom 1996;65:14–23.
Fava GA: Well-being therapy. Conceptual and technical issues. Psychother Psychosom 1999;68:171–179.
Fava GA, Rafanelli C, Cazzaro M, Conti S, Grandi S: Well-being therapy. Psychol Med 1998;28:475–480.
Fava GA, Rafanelli C, Grandi S, Conti S, Belluardo: Prevention of recurrent depression with cognitive behavioral therapy. Arch Gen Psychiatry 1998;55:816–820.
Fava GA, Ruini C, Rafanelli C, Grandi S: Cognitive behavior approach to loss of clinical effect during long-term antidepressant treatment: A pilot study. Am J Psychiatry 2002;159:2094–2095.
Ryff CD: Happiness is everything, or is it? Exploration on the meaning of psychological well-being. J Pers Soc Psychol 1989;57:1069–1083.
Rafanelli C, Park SK, Ruini C, Ottolini F, Cazzaro M, Fava GA: Rating well-being and distress. Stress Med 2000;16:55–61.
Fava GA, Rafanelli C, Ottolini F, Ruini C, Cazzaro M, Grandi S: Psychological well-being and residual symptoms in remitted patients with panic disorder and agoraphobia. J Affect Disord 2001;65:185–190.
Endicott J, Spitzer RL: A diagnostic interview: The schedule for affective disorders and schizophrenia. Arch of Gen Psychiatry 1978;35:837–844.
Paykel ES: The clinical interview for depression. Development, reliability and validity. J Affect Disord 1985;9:85–96.
Kellner R: A Symptom questionnaire. J Clin Psychiatry 1987;48:269–274.
Fava GA, Ruini C, Rafanelli C: Psychometric theory is an obstacle to the progress of clinical research. Psychother Psychosom 2004;73:145–148.
Fava GA, Grandi S, Canestrari R: Prodromal symptoms in panic disorder with agoraphobia. Am J Psychiatry 1988;145:1564–1567.
Ruini C, Ottolini F, Rafanelli C, Tossani E, Ryff CD, Fava GA: The relationship of psychological well-being to distress and personality. Psychother Psychosom 2003;72:268–275.
Fava GA, Kellner R, Perini GI, Fava M, Michelacci L, Munari F, Evangelisti LP, Grandi S, Bernardi M, Mastrogiacomo I: Italian validation of the Symptom Rating Test (SRT) and Symptom Questionnaire (SQ). Can J Psychiatry 1983;28:117–123.
Beck AT, Emery G: Anxiety Disorders and Phobias. New York, Basic Books, 1985.
Marks IM: Fears, Phobias, and Rituals. New York, Oxford University Press, 1987.
Goldthorpe JH, Hope K: The Social Grading of Occupations. Oxford, Oxford University Press, 1974.
Pesarin F: Multivariate Permutation Tests with Applications in Biostatistics. Chichester, Wiley, 2001.
Butler G, Cullington A, Hibbert G, Klimes I, Gelder M: Anxiety management for persistent generalised anxiety. Br J Psychiatry 1987;15:535–542.
Borkovec TD, Newman MG, Pincus AL, Lytle R: A component analysis of cognitive behavioral therapy for generalized anxiety disorder and the role of interpersonal problems. J Consult Clin Psychol 2002;70:288–298.
Marks IM: Fear reduction by psychotherapies. Br J Psychiatry 2002;176:507–511.
Ballenger JC, Davidson RT, Lecrubier Y, Nutt DJ, Borkovec TD, Rickels K, Stein DJ, Wittchen HU: Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry 2002;62(suppl 11):53–58.
Fava GA, Ruini C, Sonino N: Management of recurrent depression. Psychother Psychosom 2003;72:3–9.
Vaillant GE: Mental health. Am J Psychiatry 2003;160:1373–1384.
Fava GA, Ruini C: The sequential approach to relapse prevention in unipolar depression. World Psychiatry 2002;1:10–15.
Gedder JR, Rendell JM, Goodwin GM: BALANCE: A large simple trial of maintenance treatment for bipolar disorder. World Psychiatry 2002;1:48–51.
Bech P: Modern psychometrics in clinimetrics. Psychother Psychosom 2004;73:134–138.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.